It's How Medicine Should Be®

Font Size:

-A +A

Translate

French German Italian Portuguese Russian

Glioblastoma Multiforme Vaccine Trial

Clinical Trial Title: 
DC Vax-Brain
Clinical Trial Protocol ID: 
11090803
Clinical Trial Investigator Name: 
Robert Aiken, MD
Clinical Trial Protocol Description: 

Vaccine trial for the treatment of glioblastoma multiforme, administered in conjunction with temozolomide and radiation therapy, which is the current, accepted standard of care.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are 18 to 70 years of age
  • Have a life expectancy greater than eight weeks
  • Are willing to consent to tumor tissue sampling prior to surgery
  • Have a tumor that is unilateral and may involve, but not cross, the corpus callosum

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Brain Tumors
Contact Phone: 
(312) 942-4500
Contact Name: 
Amanda Begley